Iqvia Holdings (IQV) Total Non-Current Liabilities (2012 - 2026)
Iqvia Holdings (IQV) posted Total Non-Current Liabilities of $22.9 billion for Q2 2026, up 1.0% sequentially from $22.7 billion in Q1 2026, and up 3.43% YoY from $22.2 billion in Q2 2025.
Iqvia Holdings (IQV) Total Non-Current Liabilities (2012 - 2026) Analysis & Trends
Iqvia Holdings has reported Total Non-Current Liabilities for 15 years, with the latest figure at $22.9 billion in Q2 2026.
- Quarterly Total Non-Current Liabilities rose 3.43% year-over-year to $22.9 billion in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $22.9 billion (up 3.43% YoY) and the FY2025 annual result came in at $22.6 billion, up 12.21% from the prior year.
- Total Non-Current Liabilities rose to $22.9 billion in Q2 2026 per IQV's latest filing, from $22.7 billion in the prior quarter.
- Over five years, Total Non-Current Liabilities peaked at $22.9 billion in Q2 2026 and troughed at $18.3 billion in Q3 2022.
- A 5-year average of $20.2 billion and a median of $19.6 billion in 2024 frame the typical range for Total Non-Current Liabilities.
- The sharpest annual moves came in 2024 and 2025: Total Non-Current Liabilities fell 2.72% in 2024, then increased 16.39% in 2025.
- Over 5 years, Total Non-Current Liabilities stood at $19.4 billion in 2022, then grew by 2.43% to $19.9 billion in 2023, then increased by 1.47% to $20.2 billion in 2024, then advanced by 12.21% to $22.6 billion in 2025, then grew by 1.37% to $22.9 billion in 2026.
- According to Business Quant data, Total Non-Current Liabilities over the past three periods registered $22.9 billion, $22.7 billion, and $22.6 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn | 108.64 Bn |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn | 85.84 Bn |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn | 715.49 Mn |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn | 5.45 Bn |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn | 22.94 Bn |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn | 542.10 Mn |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn | 6.36 Bn |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn | 3.39 Bn |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn | 9.19 Bn |
| 10 | Quest Diagnostics | 27.10 Bn | 26.47 Bn | 1.03 Bn | 15.88 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 22.94 Bn |
| Mar 31, 2026 | 22.71 Bn |
| Dec 31, 2025 | 22.63 Bn |
| Sep 30, 2025 | 21.74 Bn |
| Jun 30, 2025 | 22.18 Bn |
| Mar 31, 2025 | 20.66 Bn |
| Dec 31, 2024 | 20.16 Bn |
| Sep 30, 2024 | 19.60 Bn |
| Jun 30, 2024 | 19.05 Bn |
| Mar 31, 2024 | 19.64 Bn |
| Dec 31, 2023 | 19.87 Bn |
| Sep 30, 2023 | 19.49 Bn |
| Jun 30, 2023 | 19.59 Bn |
| Mar 31, 2023 | 19.17 Bn |
| Dec 31, 2022 | 19.40 Bn |
| Sep 30, 2022 | 18.32 Bn |
| Jun 30, 2022 | 18.50 Bn |
| Mar 31, 2022 | 18.47 Bn |
| Dec 31, 2021 | 18.57 Bn |
| Sep 30, 2021 | 18.11 Bn |